Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy.

Aronica E, Fluiter K, Iyer A, Zurolo E, Vreijling J, van Vliet EA, Baayen JC, Gorter JA.

Eur J Neurosci. 2010 Mar;31(6):1100-7. doi: 10.1111/j.1460-9568.2010.07122.x. Epub 2010 Feb 26.

PMID:
20214679
2.

Tuning and fine-tuning of synapses with adenosine.

Sebastião AM, Ribeiro JA.

Curr Neuropharmacol. 2009 Sep;7(3):180-94. doi: 10.2174/157015909789152128.

3.

Altered function of the SCN1A voltage-gated sodium channel leads to gamma-aminobutyric acid-ergic (GABAergic) interneuron abnormalities.

Martin MS, Dutt K, Papale LA, Dubé CM, Dutton SB, de Haan G, Shankar A, Tufik S, Meisler MH, Baram TZ, Goldin AL, Escayg A.

J Biol Chem. 2010 Mar 26;285(13):9823-34. doi: 10.1074/jbc.M109.078568. Epub 2010 Jan 25.

4.

Directed evolution of a novel adeno-associated virus (AAV) vector that crosses the seizure-compromised blood-brain barrier (BBB).

Gray SJ, Blake BL, Criswell HE, Nicolson SC, Samulski RJ, McCown TJ, Li W.

Mol Ther. 2010 Mar;18(3):570-8. doi: 10.1038/mt.2009.292. Epub 2009 Dec 29. Erratum in: Mol Ther. 2010 May;18(5):1054. Li, Wuping [added].

5.

Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex.

Lusardi TA, Farr CD, Faulkner CL, Pignataro G, Yang T, Lan J, Simon RP, Saugstad JA.

J Cereb Blood Flow Metab. 2010 Apr;30(4):744-56. doi: 10.1038/jcbfm.2009.253. Epub 2009 Dec 16.

6.

miR-146a is critical for endotoxin-induced tolerance: IMPLICATION IN INNATE IMMUNITY.

Nahid MA, Pauley KM, Satoh M, Chan EK.

J Biol Chem. 2009 Dec 11;284(50):34590-9. doi: 10.1074/jbc.M109.056317. Epub 2009 Oct 19.

7.

Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures.

Liu DZ, Tian Y, Ander BP, Xu H, Stamova BS, Zhan X, Turner RJ, Jickling G, Sharp FR.

J Cereb Blood Flow Metab. 2010 Jan;30(1):92-101. doi: 10.1038/jcbfm.2009.186. Epub 2009 Sep 2.

8.

Uncoupling of astrogliosis from epileptogenesis in adenosine kinase (ADK) transgenic mice.

Li T, Lan JQ, Boison D.

Neuron Glia Biol. 2008 May;4(2):91-9. doi: 10.1017/S1740925X09990135. Epub 2009 Aug 13.

9.

Severe epilepsy syndromes of early childhood: the link between genetics and pathophysiology with a focus on SCN1A mutations.

Stafstrom CE.

J Child Neurol. 2009 Aug;24(8 Suppl):15S-23S. doi: 10.1177/0883073809338152. Review.

PMID:
19666879
10.

Allele-specific RNAi mitigates phenotypic progression in a transgenic model of Alzheimer's disease.

Rodríguez-Lebrón E, Gouvion CM, Moore SA, Davidson BL, Paulson HL.

Mol Ther. 2009 Sep;17(9):1563-73. doi: 10.1038/mt.2009.123. Epub 2009 Jun 16.

11.

Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies.

Boison D.

Epilepsy Res. 2009 Aug;85(2-3):131-41. doi: 10.1016/j.eplepsyres.2009.03.019. Epub 2009 May 9. Review.

12.

Knockdown and overexpression of NR1 modulates NMDA receptor function.

Kalev-Zylinska ML, Symes W, Young D, During MJ.

Mol Cell Neurosci. 2009 Aug;41(4):383-96. doi: 10.1016/j.mcn.2009.04.003. Epub 2009 Apr 24.

13.

RNAi inhibits Coriaria lactone-induced MDR1b overexpression in rat brain microvascular endothelial cells.

Tian L, Chen L, Yang T, Zhang Q, Zhou D.

J Mol Neurosci. 2009 Sep;39(1-2):284-93. doi: 10.1007/s12031-009-9198-3. Epub 2009 Apr 9.

PMID:
19357816
14.

Adeno-associated virus vector-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity.

McCown TJ.

Neurotherapeutics. 2009 Apr;6(2):307-11. doi: 10.1016/j.nurt.2009.01.004. Review.

15.

Neuropeptide Y overexpression using recombinant adeno-associated viral vectors.

Noé F, Frasca A, Balducci C, Carli M, Sperk G, Ferraguti F, Pitkänen A, Bland R, Fitzsimons H, During M, Vezzani A.

Neurotherapeutics. 2009 Apr;6(2):300-6. doi: 10.1016/j.nurt.2009.01.012. Review.

16.

Engineered adenosine-releasing cells for epilepsy therapy: human mesenchymal stem cells and human embryonic stem cells.

Boison D.

Neurotherapeutics. 2009 Apr;6(2):278-83. doi: 10.1016/j.nurt.2008.12.001. Review.

17.

Human mesenchymal stem cell grafts engineered to release adenosine reduce chronic seizures in a mouse model of CA3-selective epileptogenesis.

Li T, Ren G, Kaplan DL, Boison D.

Epilepsy Res. 2009 Apr;84(2-3):238-41. doi: 10.1016/j.eplepsyres.2009.01.002. Epub 2009 Feb 12.

18.

Inherited neuronal ion channelopathies: new windows on complex neurological diseases.

Catterall WA, Dib-Hajj S, Meisler MH, Pietrobon D.

J Neurosci. 2008 Nov 12;28(46):11768-77. doi: 10.1523/JNEUROSCI.3901-08.2008. Review.

19.

Gene therapy in epilepsy.

Riban V, Fitzsimons HL, During MJ.

Epilepsia. 2009 Jan;50(1):24-32. doi: 10.1111/j.1528-1167.2008.01743.x. Epub 2008 Aug 19. Review.

20.

Adenosine dysfunction in astrogliosis: cause for seizure generation?

Li T, Quan Lan J, Fredholm BB, Simon RP, Boison D.

Neuron Glia Biol. 2007 Nov;3(4):353-66. doi: 10.1017/S1740925X0800015X.

Supplemental Content

Support Center